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Background: The quality of life (QOL) of patients with autosomal dominant polycystic kidney disease (ADPKD) has
not been investigated well. This study was performed to clarify the QOL of patients with ADPKD and to identify
factors that affected their QOL.
Methods: The present cross-sectional study is part of a prospective observational study on the QOL of ADPKD
patients. Patients with ADPKD who were referred to Toranomon Hospital between March 2010 and November 2012
were enrolled. The short form-36 (SF-36) questionnaire and our original 12-item questionnaire were used to
evaluate QOL. We analyzed the results of the questionnaire survey and then investigated correlations between QOL
and clinical features.
Results: A total of 219 patients (93 men and 126 women) were enrolled and their mean age was 55.1±10.8 years.
There were 108 patients on dialysis. The SF-36 scores (PCS, MCS, and RCS) of all patients were significantly lower
than the mean scores for the Japanese population. Stepwise multiple regression analysis demonstrated that Hb,
serum Alb, ascites, and cerebrovascular disease all had a significant influence on the PCS, while mental disease had
a significant influence on the MCS and serum Alb significantly influenced the RCS. The total liver and kidney
volume (TLKV) and the dialysis status were not significantly associated with any of the SF-36 scores by multiple
regression analysis, but TLKV was closely correlated with abdominal distention and distention had an important
influence on QOL. Pain, sleep disturbance, heartburn, fever, gross hematuria, and anorexia also affected QOL, but
these variables were not correlated with TLKV.
Conclusions: Several factors influence QOL, so improving symptoms unrelated to TLKV as well as reducing
abdominal distention can improve the QOL of ADPKD patients.
Keywords: Quality of life, Polycystic kidney disease, Dialysis, Total liver and kidney volumeBackground
Autosomal dominant polycystic kidney disease (ADPKD)
is a common disorder that occurs in approximately 1 in
every 400 to 1000 live births [1,2]. It is estimated that
less than one-half of ADPKD patients will be diagnosed
during life because the disease is often clinically silent
[1]. However, some patients with ADPKD develop massive
enlargement of the kidneys and/or liver. We have per-
formed renal transcatheter arterial embolization (TAE) in
797 symptomatic patients with renal enlargement and hep-
atic TAE in 325 symptomatic patients with hepatomegaly* Correspondence: suwabe@toranomon.gr.jp
Department of Nephrology, Toranomon Hospital, Tokyo, Japan
© 2013 Suwabe et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orup to November 2012, and we have previously reported
that TAE is an effective method of reducing the hepatic or
renal volume [3-6]. Most of our patients who received
renal or hepatic TAE had symptoms related to abdominal
distension and their quality of life (QOL) was obviously
impaired. It has been reported that ADPKD affects the
physical condition of patients and also has an impact on
mental health [7]. Pain is a common symptom of ADPKD
and it has a detrimental effect on QOL [8,9], but the QOL
of ADPKD patients and the factors influencing it have not
been clarified. Recently, the TEMPO study showed that
tolvaptan slows the increase of total kidney volume and the
decline of renal function in patients with ADPKD [10], butl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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volume and renal function. Rizk et al. evaluated the
QOL of predialysis patients with ADPKD by the short
form-36 (SF-36) questionnaire and they reported that
such patients did not have worse QOL than the general
population [11]. They also reported that the QOL of pa-
tients with a mean renal volume over 1000 cm3 was not
significantly different from that of patients with a mean
volume under 1000 cm3, but they did not assess the in-
fluence of hepatic volume. The average renal volume of
the patients receiving renal TAE at our hospital was
over 2000 cm3 [3], and some of our predialysis patients
also had severe hepatomegaly (Figure 1). We considered
that the mean renal volume in Rizk’s study might have
been too small to affect QOL and that hepatic volume
should also be taken into account. Therefore, we started
to investigate the QOL of ADPKD patients who were
referred to our hospital for massive enlargement of the
kidneys or liver, employing the SF-36 questionnaire and
our original 12-item questionnaire to evaluate QOL. The
SF-36 questionnaire is one of the most common methods
of evaluating QOL worldwide, as well as in Japan [12-14].
Because mean SF-36 scores for the general Japanese popu-
lation are available, it is easy to evaluate the QOL of pa-
tients by comparison with the general population. We also
devised twelve questions of our own to evaluate the spe-
cific symptoms of patients with ADPKD.
In the present study, we employed these tools to clar-
ify the QOL of ADPKD patients with massive enlarge-
ment of the kidneys and/or liver and to identify factors
affecting their QOL.Figure 1 A non-dialysis ADPKD patient with massive hepatomegaly.Methods
This was a cross-sectional study that was part of a pro-
spective observational study on the QOL of patients
with ADPKD. This study was reviewed and approved by
the ethics committee of Toranomon Hospital in March
2010. Written informed consent was obtained from each
participant before entry into the study, and also for pub-
lication of any accompanying images. A copy of the writ-
ten consent for publication statement is available for
review by the Editor of this journal. This study was regis-
tered with the University Hospital Medical Information
Network (UMIN) as “Quality of life (QOL) of patients with
autosomal dominant polycystic kidney disease (ADPKD):
Influence of renal TAE or hepatic TAE on QOL”. All clin-
ical information was obtained from the medial database of
Toranomon Hospital.Patient population
All patients with ADPKD who were referred to Toranomon
Hospital between March 2010 and November 2012 were
enrolled in this study. Patients who were less than 20 years
old, patients who received renal or hepatic TAE before
March 2010, and patients who did not agree to participate
in this research were excluded. Patients on CAPD were also
excluded because abdominal distention might be influenced
by their dialysis method. All enrolled patients met the
criteria for diagnosis of ADPKD as defined by Ravine
et al. [15]. Some patients underwent renal or hepatic
TAE after being enrolled, but others did not undergo
TAE up to November 2012.
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Patients completed the self-administered questionnaires
during their free time. They were requested to fill in the
questionnaires while they were in a normal state. All pa-
tients who underwent renal or hepatic TAE completed the
questionnaires before having the procedure. The question-
naires included the Short Form-36 questionnaire (SF-36)
and our 12-item original questionnaire. The SF-36 con-
tains 36 questions that evaluate eight dimensions: physical
functioning, physical role function, body pain, general
health perception, vitality, social function, emotional role
function and mental health. The scores for these dimen-
sions are then totalled to obtain a physical component
summary score (PCS), a mental component summary score
(MCS), and a role/social component summary score (RCS).
These scores have been validated in various studies of mul-
tiple chronic illnesses and have been normalized for the
general Japanese population (a mean value of 50 and an SD
of 10). The mean age of the general Japanese population is
50.5 ± 15.9 years. We also devised 12 questions about spe-
cific symptoms of patients with ADPKD, such as abdominal
distension, poor appetite, and sleep disturbance (Table 1).
Each symptom was assigned a score of 1–4 or 1–5, with 1
being the most severe.
Clinical and laboratory assessments
Height and body weight were recorded when the sub-
jects filled in the questionnaires. Dry weight was used as
the body weight of dialysis patients. Body mass index
(BMI) was calculated as the weight in kilograms divided
by the square of the height in meters. All patients under-
went laboratory tests while they were in their usual state
and within one week before or after filling in the ques-
tionnaires. The past history was investigated from the
medical records of Toranomon Hospital and all associ-
ated diseases with a medical diagnosis were identified
from the records. With regard to the past history, we an-
alyzed the influence on QOL of cardiovascular disease,Table 1 Our original 12-item questionnaire
(Q1) Can you cut your toenails by yourself?
(Q2) Can you pick up something from the floor?
(Q3) Do you feel abdominal distention?
(Q4) Dou you suffer from heartburn?
(Q5) How is your appetite?
(Q6) How often do you take sleeping pills?
(Q7) Dou you sleep well?
(Q8) Do you snore?
(Q9) How often do you take a purgative?
(Q10) How often do you have constipation?
(Q11) How often do you have fever of more than 38°C?
(Q12) How often do you have gross hematuria?cerebrovascular disease, cancer, mental disease, and dia-
betes mellitus.
Imaging studies
Abdominal CT or MRI was routinely performed in all pa-
tients and images obtained within 3 months before or after
entry into this study were used for evaluation of organ vol-
umes. For all patients who received renal or hepatic TAE
after being enrolled in this study, the abdominal CT or
MRI studies obtained before TAE were used for evaluation
of organ volume because it would have changed after TAE.
T1-weighted images (T1WI) and T2-weighted images
(T2WI) obtained in the transverse and sagittal planes were
employed for evaluation of organ size by MRI, which was
performed with a 1.5-T apparatus (MagnetomAvanto,
Siemens, Erlangen, Germany) and a phased-array body
coil. CT scanning was performed with a 16-MDCT scan-
ner (Aquilion 16, Toshiba).
Renal volume was calculated on CT scans using the
formula for an ellipsoid: a*b* c*π/6, where a is the max-
imum length of the kidney and b and c are the max-
imum widths in the two transverse dimensions. Each CT
scan obtained at a slice interval of 1 cm was analyzed
using Synapse software (Fujifilm Company) and the hep-
atic area (cysts plus parenchyma) was measured. Then
the total liver volume was calculated as the sum of all
the hepatic areas, while the total liver and kidney volume
(TLKV) was obtained by adding total liver volume and
the kidney volumes calculated as mentioned above. The
existence of ascites was assessed by two different readers
who were specialists in nephrology and radiology.
Statistical analysis
The mean PCS, MCS, RCS, and specific component scores
were calculated for the overall study population. For quan-
titative discrete variables, differences between groups
were assessed by using Student’s t-test or the Mann-
Whitney U test.
The values of PCS, MCS, and RCS were compared be-
tween the patients and the general Japanese population by
the one sample t-test. Correlations between PCS, MCS, or
RCS and TLVK were assessed by univariate analysis.
Stepwise multiple regression analysis with forward elim-
ination was used to analyze the factors related to PCS,
MCS, and RCS. These three indicators of QOL were de-
fined as the dependent variable, while age, sex, BMI, dialy-
sis, duration of dialysis, ascites, TLKV, serum Alb, CRP, Cr,
alkaline phosphatase (ALP), cholinesterase (ChE), Hb, car-
diovascular disease, cerebrovascular disease, cancer, mental
disease, and diabetes mellitus were defined as the explana-
tory variables. The TLKV of each patient was adjusted by
the body surface areafor use in all analyses.
The answers to our 12-item questionnaire were ex-
pressed on an ordinal scale and correlations with the three
Table 2 Profile of the enrolled patients
M/F Age
(years old)













All 93/126 55.1±10.8 22.7±4.1 74.5±61.8 3.48±0.41 230.8±68.6 2.08±1.89 0.33±0.69 247.2±126.3 11.48±1.71
Non-dialysis 44/67 52.3±11.9* 23.4±5.0† 3.71±0.32* 265.8±72.5* 2.08±1.89 0.21±0.39‡ 240.6±116.5 12.22±1.72*
Dialysis 49/59 57.9±8.7* 21.9±2.4† 74.5±61.8 3.23±0.34* 201.2±48.6* 0.45±0.88‡ 253.9±135.9 10.72±1.34*
No. of patients with
ascites (/patients available
abdominal image data)


















No of patients with diabetes
31/176 3573.1±3088.7 3908.6±2578.3 7457.2±3801.6 21 21 11 5 2
10/72 3841.2±3550.9 3308.1±2566.2* 7073.6±4175.2‡ 8 13 7 4 2
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correlation coefficient analysis. Factor analysis was em-
ployed for multivariate analysis of the relations among the
three SF-36 scores and each of our 12 questions. Promax
rotation was used for factor analysis because the under-
lying factors were all considered to be correlated with each
other to some extent. Because pain is a common symptom
of ADPKD and has a detrimental influence on QOL [8,9],
a question about pain was included in the SF-36 and the
score was used to assess the relation between pain and
other SF-36 scales or TLKV by Spearman’s rank correl-
ation coefficient analysis. Factor analysis was also employed
for multivariate analysis of the relations among pain and
the three SF-36 scores. In all analyses, P<0.05 was consid-
ered to indicate significance, and all analyses were per-
formed with the SPSS Statistics 18.0 statistical software
package (SPSS Inc., Chicago, IL, USA).
Results
A total of 219 patients were enrolled in this study, including
93 men and 126 women with a mean age of 55.1 ± 10.8
years. Among them, 108 patients were on hemodialysis
(Table 2). Up to November 2012, 85 patients received renal
TAE and 28 patients received hepatic TAE. Abdominal CT
or MRI data for evaluation of TLKV were available in 173
patients.
The three SF-36 scores (PCS, MCS, and RCS) of all
patients were significantly lower than those of the gen-
eral Japanese population (Figure 2). In addition, the PCS
of patients aged from their 40s to 60s and the MCS and
RCS of patients aged from their 50s to 60s were lowerFigure 2 Comparison of the SF-36 scores (PCS, MCS, and RCS) for all
general Japanese population.than those of the general Japanese population when ana-
lysis was performed by age group (Table 3). Among all
non-dialysis patients, the PCS was significantly lower
than the mean value for the general Japanese population
(Figure 2). The PCS of non-dialysis patients from their
40s to 60s was also significantly lower than that of the
general Japanese population (Table 3). Comparing non-
dialysis patients with dialysis patients, the PCS was signifi-
cantly lower for dialysis patients than non-dialysis patients,
while the MCS and RCS did not differ between the two
groups (Figure 2). Dialysis patients were older and had a
lower BMI, lower Hb, lower serum ChE and Alb levels,
and higher serum CRP level than non-dialysis patients
(Table 2).
Univariate analysis revealed that PCS was correlated
with TLKV, though MCS and PCS were not (Figure 3).
Stepwise multiple regression analysis demonstrated that
Hb serum Alb, ascites, and cerebrovascular disease were
variables with a significant influence on PCS, while mental
disease was the variable significantly influencing MCS and
serum Alb was the only variable influencing RCS (Table 4).
TLKV and dialysis were not significantly related to any of
the SF-36 scores.
Among our original questions, Q1-7, Q11, Q12, and pain
were significantly correlated with PCS by Spearman’s rank
correlation analysis (Table 5), while Q1 and Q3 were corre-
lated with TLKV. Thus, only Q1 and Q3 were correlated
with both PCS and TLKV. According to factor analysis,
PCS, Q3-5, and Q12 had high positive factor loadings,
while PCS and Q11 had high negative factor loadings for
the first factor (Table 6). Then PCS, Q1, and Q2 had highenrolled patients, non-dialysis patients, dialysis patients, and the
Table 3 Comparison of PCS, MCS, and RCS Comparison of PCS, MCS, and RCS between ADPKD patients and the
general Japanese population
Group Item Age group (decades) No. of patients Mean SD SEM P value*
All patients PCS 30s 17 52.1 7.6 1.9 NS
40s 52 44.2 13.4 1.9 <0.001
50s 73 41.8 11.6 1.4 <0.001
60s 58 36.2 14.9 2.0 <0.001
70s 19 41.2 11.7 2.7 NS
MCS 30s 17 52.7 10.5 2.5 NS
40s 52 46.7 9.5 1.3 NS
50s 73 47.6 7.7 0.9 <0.05
60s 58 45.9 10.5 1.4 <0.001
70s 19 55.7 8.2 1.9 NS
RCS 30s 17 50.1 12.5 3.0 NS
40s 52 47.6 15.5 2.2 NS
50s 73 45.8 14.6 1.7 <0.001
60s 58 46.0 17.3 2.3 <0.01
70s 19 44.8 13.8 3.2 NS
Non-dialysis patients PCS 30s 15 52.7 7.9 2.1 NS
40s 34 47.6 13.0 2.2 <0.05
50s 29 44.7 11.1 2.1 <0.05
60s 23 37.9 17.3 3.6 0.001
70s 10 43.4 11.8 3.7 NS
MCS 30s 15 52.2 11.0 2.8 NS
40s 34 47.0 10.2 1.7 NS
50s 29 45.6 7.4 1.4 <0.01
60s 23 48.4 11.0 2.3 0.05
70s 10 57.4 4.5 1.4 NS
RCS 30s 15 52.1 8.5 2.2 NS
40s 34 47.9 14.0 2.4 NS
50s 29 47.5 14.0 2.6 0.01
60s 23 49.5 13.4 2.8 NS
70s 10 50.1 11.9 3.8 NS
Dialysis patients PCS 30s 2 47.5 0.6 0.5 NS
40s 18 37.7 11.9 2.8 <0.001
50s 44 40.0 11.7 1.8 <0.001
60s 35 35.1 13.2 2.2 <0.001
70s 9 38.8 11.8 3.9 NS
MCS 30s 2 56.3 6.1 4.3 NS
40s 18 45.9 8.2 1.9 NS
50s 44 49.0 7.6 1.2 NS
60s 35 44.2 9.9 1.7 <0.001
70s 9 53.8 10.9 3.6 NS
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Table 3 Comparison of PCS, MCS, and RCS Comparison of PCS, MCS, and RCS between ADPKD patients and the
general Japanese population (Continued)
RCS 30s 2 35.2 31.4 22.2 <0.05
40s 18 47.1 18.5 4.4 NS
50s 44 44.6 15.0 2.3 <0.001
60s 35 43.7 19.3 3.3 0.001
70s 9 38.8 13.9 4.6 NS
* Comparison with the data of general Japanese population was analyzed in each age group.
SD: Standard Deviation, SE: standard error of the mean, NS: not significant.
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second factor has higher positive factor loadings than the
first factor, Q1 and Q2 (with high positive loadings for
the second factor) were considered to be better corre-
lated with PCS than Q3. Since Q3-5, Q7, Q12, and pain
were significantly correlated with MCS, Q3 was the only
question correlated with both MCS and TLKV (Table 5).
Factor analysis also showed that MCS, Q3-5, and Q12
had high positive factor loadings, while MCS and pain
had high negative factor loadings for the first factor
(Table 7). Since Q1-4, Q6, Q11, and pain were signifi-
cantly correlated with RCS, only Q1 and Q3 were corre-
lated with both RCS and TLKV (Table 5). Furthermore,
RCS, Q7, and Q11 had high positive factor loadings,
while RCS, Q5, and pain had high negative factor load-
ings for the second factor (Table 8).
Discussion
Rizk et al. reported that the SF-36 score of non-dialysis
ADPKD patients was not significantly different from that
of the general population. In the present study, however,
the PCS of non-dialysis ADPKD patients was signifi-
cantly lower than that of the general Japanese popula-
tion. Our analysis stratified for age groups also showedFigure 3 Univariate regression analysis of the relation between
PCS and TLKV.that the PCS of non-dialysis patients from their 40s to
60s was significantly lower than that of the general Japanese
population. This difference from the findings of Rizk et al.
may have occurred because the mean kidney volume of the
non-dialysis patients in our study was much larger than
that of the patients they investigated. PCS was significantly
lower in dialysis patients than non-dialysis patients, but age,
nutritional status, and kidney volume were significantly dif-
ferent between the two groups.
It was reasonable that ascites and cerebrovascular dis-
ease were variables with a significant influence on PCS
and mental disease was significantly associated with MCS.
Serum Alb might reflect the nutritional status which is
influenced by multiple factors, including the appetite, liver
function, renal function, TLKV, and lifestyle. Then, it
might not doubtful that Alb was significant variable for
PCS and RCS. It might be the same reason for association
Hb and PCS.
TLKV and dialysis were not significantly associated
with any of the SF-36 scores by stepwise multiple regres-
sion analysis. However, univariate analysis revealed that
PCS was correlated with TLKV, so TLKV seems to have
an important influence on PCS. It seems that PCS was
not only affected by abdominal distention (strongly cor-
related with TLKV), but also by several symptoms unre-
lated to TLKV. Accordingly, there should be multiple
factors that influence the QOL of ADPKD in addition to






β P value Adjusted R2
PCS Alb 0.223 <0.01 0.187
Hb 0.161 <0.05
Ascites -0.214 <0.005
Cerebrovascular disease -0.193 <0.01
MCS mental disease −0.171 <0.05 0.023
RCS Alb 0.247 0.001 0.055
β: Standardized regression coefficient.
Variables included in the model were age, sex, BMI, dialysis, dialysis duration,
ascites, TLKV, Alb, CRP, Cr, ALP, ChE, Hb, cardiovascular disease,
cerebrovascular disease, cancer, mental disease, and diabetes.
Table 5 Spearman’s rank correlation coefficient (original questions vs. three SF-36 scores, and original
questions vs. TLKV)
PCS MCS RCS TLKV
Question rs p rs P rs P rs P
Q1 0.313 <0.001 0.127 NS 0.198 <0.005 −0.189 <0.05
Q2 0.366 <0.001 0.090 NS 0.337 <0.001 −0.148 NS
Q3 0.450 <0.001 0.357 <0.001 0.306 <0.001 −0.328 <0.001
Q4 0.235 0.001 0.388 <0.001 0.210 <0.005 0.044 NS
Q5 0.274 <0.001 0.379 <0.001 0.133 NS −0.092 NS
Q6 0.189 <0.05 0.135 NS 0.179 <0.05 0.066 NS
Q7 0.290 <0.001 0.267 <0.001 0.126 NS −0.072 NS
Q8 −0.009 NS 0.084 NS −0.009 NS 0.077 NS
Q9 0.116 NS 0.037 NS 0.003 NS −0.148 NS
Q10 0.007 NS 0.010 NS 0.004 NS 0.117 NS
Q11 0.162 <0.05 0.095 NS 0.163 <0.05 −0.030 NS
Q12 0.266 <0.001 0.163 <0.05 0.017 NS −0.077 NS
Pain −0.582 <0.001 −0.437 <0.001 −0.193 <0.005 −0.083 NS
rs: Spearman’s rank correlation coefficient, NS: not significant.
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analysis. In addition, factor analysis revealed that Q1 and
Q2 were more closely associated with PCS than Q3. Thus,
the ability to cut toenails or to pick up something from
the floor affected PCS more than abdominal distention.Table 6 Results of factor analysis of the PCS: Promax
(oblique) rotated factor patterns
I II III IV V
PCS 0.360 0.633 0.052 0.046 −0.059
Q1 −0.065 0.825 −0.012 0.041 −0.082
Q2 −0.045 0.847 0.135 −0.054 −0.006
Q3 0.739 0.273 −0.086 0.064 0.113
Q4 0.757 −0.122 0.191 −0.226 −0.112
Q5 0.843 −0.082 −0.309 0.015 −0.048
Q6 0.129 −0.109 −0.001 0.728 0.229
Q7 0.192 0.053 0.584 −0.124 0.024
Q8 0.007 −0.162 0.261 0.083 0.632
Q9 −0.214 0.145 −0.076 0.797 −0.176
Q10 0.051 −0.006 0.132 0.033 −0.805
Q11 −0.328 0.149 0.915 0.001 0.057
Q12 0.327 −0.269 0.380 0.290 −0.198
pain −0.495 −0.287 −0.127 −0.076 −0.127
Inter-factor correlations
I - 0.225 0.424 0.206 0.037
II 0.225 - 0.159 0.095 −0.024
III 0.424 0.159 - 0.173 0.025
IV 0.206 0.095 0.173 - −0.074
V 0.037 −0.024 0.025 −0.074 -These abilities might be associated with muscular strength
and balance as well as abdominal distension.
TLKV was also not significantly associated with MCS
on multiple regression analysis. One of the reasons was
that mental disease was a significant variable, but ourTable 7 Results of factor analysis of the MCS: Promax
(oblique) rotated factor patterns
I II III IV V
MCS 0.776 −0.194 −0.070 0.017 0.130
Q1 0.059 0.829 −0.026 0.077 −0.066
Q2 0.020 0.858 0.200 −0.037 −0.001
Q3 0.729 0.312 −0.056 0.089 0.066
Q4 0.721 −0.052 0.178 −0.222 −0.162
Q5 0.762 0.021 −0.243 0.014 −0.109
Q6 0.161 −0.084 −0.004 0.733 0.214
Q7 0.253 0.058 0.503 −0.107 0.015
Q8 −0.070 −0.139 0.398 0.053 0.563
Q9 −0.195 0.144 −0.056 0.792 −0.175
Q10 −0.023 −0.007 0.140 0.011 −0.825
Q11 −0.246 0.165 0.891 −0.027 0.045
Q12 0.248 −0.262 0.429 0.259 −0.263
pain −0.531 −0.214 −0.200 −0.062 −0.121
Inter-factor correlations
I - 0.063 0.379 0.168 0.015
II 0.063 - 0.082 0.027 −0.060
III 0.379 0.082 - 0.143 −0.005
IV 0.168 0.027 0.143 - −0.081
V 0.015 −0.060 −0.005 −0.081 -
Table 8 Results of factor analysis of the RCS: Promax
(oblique) rotated factor patterns
I II III IV V VI
RCS 0.097 0.644 0.077 0.093 0.254 −0.223
Q1 0.103 −0.073 0.864 0.033 −0.054 −0.017
Q2 0.085 0.103 0.858 −0.083 −0.034 0.082
Q3 0.736 0.087 0.204 0.101 0.118 −0.023
Q4 0.678 0.294 −0.146 −0.201 −0.153 −0.086
Q5 0.848 −0.305 0.082 −0.026 −0.088 0.109
Q6 0.119 0.069 −0.193 0.760 0.155 0.043
Q7 0.130 0.680 −0.142 −0.048 −0.031 −0.122
Q8 0.050 −0.084 0.052 −0.059 0.230 0.944
Q9 −0.183 −0.082 0.145 0.789 −0.169 −0.122
Q10 0.026 −0.049 0.106 −0.035 −0.860 −0.291
Q11 −0.356 0.832 0.133 −0.030 −0.125 0.227
Q12 0.270 0.120 −0.142 0.192 −0.494 0.301
pain −0.403 −0.328 −0.131 −0.074 −0.043 −0.053
Inter-factor correlations
I - 0.381 0.073 0.173 −0.051 0.091
II 0.381 - 0.218 0.146 −0.069 0.186
III 0.073 0.218 - 0.101 0.020 −0.112
IV 0.173 0.146 0.101 - −0.098 0.084
V −0.051 −0.069 0.020 −0.098 - −0.183
VI 0.091 0.186 −0.112 0.084 −0.183 -
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ated directly with mental disease. Symptoms associated
with mental disease might have had higher positive fac-
tor loadings than abdominal distention. There was a
weaker correlation between RCS and abdominal disten-
sion according factor analysis and Spearman’s rank cor-
relation analysis. RCS might be more strongly affected
by the social and family environment of each patient,
but questions about the family and social environment
were not included in this study.
As reported before, pain was an important factor for
QOL because it was correlated with all of the SF-36
scores according to Spearman’s rank correlation analysis
and factor analysis [8,9]. Sleep disturbance, heartburn,
fever, gross hematuria and anorexia were also important
factors for QOL, while snoring and constipation were
not important factors. Though it is doubtful that gross
hematuria influenced QOL, it might be related to fever
and pain. Although pain, sleep disturbance, heartburn,
fever, gross hematuria, and anorexia were all important
for QOL, these variables were not correlated with TLKV.
Thus, improving these factors unrelated to TLKV is con-
sidered to be important for elevating the QOL of ADPKD
patients as well as reduction of abdominal distention.Against our expectations, TLKV did not have a very
strong influence on the QOL of ADPKD patients, al-
though it was considered to have some influence on QOL.
In order to reveal how TLKV affect SF-36 more clearly, we
would need to study the changes of TLKV in each patient
over time. Such a study about the changes of QOL in
ADPKD patients after renal TAE is now ongoing and it
will be able to reveal how SF-36 scores change when kid-
ney volume is dramatically reduced by renal TAE. SF-36
did not reflect sensitively TLKV or abdominal distention
in this study, so evaluation using SF-36 alone might not be
suitable for assessing the symptoms of ADPKD patients.
We will continue to use our original questions as well.
Against our expectation, dialysis did not have a signifi-
cant influence on any of the SF-36 scores. One reason
might be that QOL measured by SF-36 includes both
symptoms affected by dialysis and symptoms unrelated
to dialysis. In addition, the environment for dialysis pa-
tients (including techniques and medical expenses) is well
developed in Japan and there are almost 20,000 patients
who have been on hemodialysis for longer than 20 years
[16]. This might have affected our results as well.
The limitations of this study are that it was based on a
questionnaire and each answer was subjective. Also, only
Japanese patients were included in this study, and there
might be difference among ethnic groups and dialysis con-
ditions in Japan might be different from those elsewhere
in the world. There might also be other confounding fac-
tors that affect the QOL of ADPKD patients, but familial
and social factors were not included in this study. Finally,
the QOL of patients with ADPKD was mainly assessed
with the SF-36 in this study, but it is uncertain how ac-
curately this questionnaire reveals the actual situation of
ADPKD patients.
Conclusion
This study demonstrated that the mean PCS, MCS, and
RCS of all patients were significantly lower than those of
the general Japanese population. There was a significant
difference of PCS between dialysis and non-dialysis pa-
tients, despite no significant differences of MCS and RCS.
Even the PCS of non-dialysis patients was significantly
lower than that of the general Japanese population. Step-
wise multiple regression analysis demonstrated that Hb,
serum Alb, ascites, and cerebrovascular disease were vari-
ables with a significant influence on PCS, while mental
disease was the only significant factor for MCS and serum
Alb was the only significant factor for RCS. TLVK and dia-
lysis did not have a significant influence on any of the SF-
36 scores according to stepwise multiple regression analysis.
However, TLKV was well correlated with abdominal disten-
tion and abdominal distention was an important factor for
QOL. Pain, sleep disturbance, heartburn, fever, gross hema-
turia, and anorexia were also important factors for QOL,
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http://www.biomedcentral.com/1471-2369/14/179but were not correlated with TLKV. Thus, QOL was
considered to be a multifactorial construct and address-
ing symptoms unrelated to TLKV as well as abdominal
distention is important for improving the QOL of ADPKD
patients.
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